Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:XLRN’

James Flynn Deerfield Management

2019 Review: Top Hedge Fund Stocks vs. Acceleron Pharma Inc (XLRN)

It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a......(read more)
James Flynn Deerfield Management

Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)

Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook......(read more)
James Flynn Deerfield Management

Is Acceleron Pharma Inc (XLRN) Going to Burn These Hedge Funds?

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact,......(read more)
James Flynn Deerfield Management

Here’s What Hedge Funds Think About Acceleron Pharma Inc (XLRN)

The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or......(read more)
FARALLON CAPITAL

Is Acceleron Pharma Inc (XLRN) A Good Stock To Buy?

Is Acceleron Pharma Inc (NASDAQ:XLRN) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because......(read more)
accounting, business, accountant, chart, project, executive, plan, analyst, group, briefing, laptop, closeup, statistics, table, economics, hands, corporate, concept, success,

Former CEO of Finish Line Inc. (FINL) Sells Shares as Underperformance Persists; Other Notable Insider Transactions

It is already common knowledge that corporate insiders are savvy long-term-oriented investors, with their purchases beating broader market benchmarks......(read more)

Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined......(read more)
Daniel Gold QVT Financial

QVT Financial Reduces Exposure to Healthcare Going Into 2016; Here Are Its Top Stock Picks

QVT Financial is a New York-based long/short equity hedge fund founded by Daniel Gold in 2003. Prior to founding QVT Financial, Mr. Gold worked as a proprietary......(read more)

Hedge Funds Are Dumping Acceleron Pharma Inc (XLRN)

It’s a little-known fact that stock performance is not evenly distributed (i.e. you don’t have a 50/50 chance of picking a market-beating......(read more)
Jim Tananbaum - Foresite Capital

Foresite Capital Betting It All On These Four Healthcare Stocks

Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing......(read more)
Covidien plc (NYSE:COV)

Tekmira Pharmaceuticals Corp (TKMR): QVT Financial’s New Holding and Two Other Healthcare Picks

Daniel Gold’s QVT Financial has disclosed a new stake in Tekmira Pharmaceuticals Corp (NASDAQ:TKMR). According to the 13D Form filed with the U.S......(read more)